US biotech firms

Immunotherapy has become one of the most strategically important pillars in modern biotechnology. Over the past decade, US biotech firms have rapidly expanded their immunotherapy pipelines as advances in tumor immunology, cellular engineering, and biomarker science reshape how diseases are treated. What began largely as an oncology breakthrough has evolved into a broad therapeutic platform … Read more